(Reuters) - Shares of the specialty pharmaceutical company were trading
up nearly 7 percent, or $1.08, at $17.19 in morning trade on
the Nasdaq.
Read more at Reuters.com Market News
up nearly 7 percent, or $1.08, at $17.19 in morning trade on
the Nasdaq.
Read more at Reuters.com Market News
No comments:
Post a Comment